r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

EC

Erez Chimovits

Insider · Director and 10% owner · BRVE

Erez Chimovits files insider transactions with the SEC as a director and 10% owner of Braveheart Bio (BRVE). We hold 1 disclosed purchase or sale filed since 22 October 2018, 1 of them in the last 90 days.

  • Files forBRVE
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure11 August 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 5 August 2026 — 7 August 2026Director and 10% owner · Braveheart Bio (BRVE)5 Form 4 lines · source: SEC Form 4
  • Filed 10 October 2024 — 9 June 2026Director · Upstream Bio (UPB)11 Form 4 lines · source: SEC Form 4
  • Filed 5 December 2019 — 15 March 202410% owner · BiomX (PHGE)10 Form 4 lines · source: SEC Form 4
  • Filed 15 September 2020 — 12 February 2021Director and 10% owner · Adicet Bio (ACET)5 Form 4 lines · source: SEC Form 4
  • Filed 18 October 2018 — 1 October 2020Director and 10% owner · LogicBio Therapeutics (LOGC)11 Form 4 lines · source: SEC Form 4
  • Filed 2 May 2019 — 14 January 2020Director and 10% owner · Novus Therapeutics (NVUS)6 Form 4 lines · source: SEC Form 4

Everything they disclosed

48 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.